FOLFIRI

confirmed Ras-B-Raf wild-type MSS, MCRC.

They were treated with first-line Folfiri Cetuximab.

And then at first, disease progression, PD, if Foundation 1 liquid NGS is what they use, indicates a Ras-B-Raf mutant, they would switch to second-line Fofox Bev.

But if they remain RAS, BRAF wild type, they actually switch to second-line full-floxetuximab.

Yep

... you, you, you can give it With, you know, you know, say FOLFOX in front line and then FOLFIRI in second line.

I mean-

Yep